ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1023

Characterization of Phenotypic Differences in IgG4-Related Disease Across the Sexes

Grace McMahon1, Isha Jha1, Aubree McMahon1, Ana Fernandes1, Zachary Wallace2, Guy Katz1, Cory Perugino1 and John Stone3, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Newton, MA, 3Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Concord, MA

Meeting: ACR Convergence 2023

Keywords: gender, IgG4 Related Disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1013–1032) Healthcare Disparities in Rheumatology Poster II: Socioeconomic Determinants

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: IgG4-related disease (IgG4-RD) is a multi-organ fibroinflammatory disease with an autoimmune basis that can affect essentially any organ. Differences in phenotypic expression between males and females have been observed in case series features of individual organ involvement. We aimed to characterize sex differences in IgG4-RD using baseline data from the Massachusetts General Hospital (MGH) IgG4-RD cohort.

Methods: Subjects were recruited between 2008 and 2023 and classified by ACR/EULAR Classification Criteria. Age at diagnosis, disease activity, treatment status, organ involvement, pre-treatment laboratory values, and blood plasmablast concentrations were collected at baseline. Active disease was defined as IgG4-RD-associated inflammation in at least one organ, such that the IgG4-RD Responder Index score was > 0. Laboratory values are reported only on patients who had active IgG4-RD and were untreated at baseline. The study was approved by the MassGeneral Brigham IRB.

Results: Of the 564 participants enrolled in the MGH Registry for IgG4-RD, 328 fulfilled ACR/EULAR Classification Criteria and were included. There was a strong male predominance: 226 males (69%) versus 102 (31%) females [Table 1]. This M:F ratio of 2.2:1.0 contrasts markedly with both that of the general population (1:1) (P < 0.001) and our general clinic population (0.4:1.0) (P < 0.001). Male patients were five years older on average at the time of diagnosis (61.6 vs 56.6; P < 0.01) and disproportionately more likely to have involvement of the pancreas, kidneys, lymph node, aorta, large blood vessels, coronary arteries, and retroperitoneum. Females had higher involvement in the lacrimal and submandibular glands than males (for all organ involvement comparisons, P < 0.05) [Figure 1]. We examined laboratory values in 127 (39%) subjects who had active IgG4-RD and were untreated at baseline. Males were more likely to be serologically active at baseline as defined by serum IgG4, IgG1, and IgE concentrations. The mean serum IgG4 concentration in males was 620 mg/dl (±684) versus 412 mg/dl (±543) for females (P = 0.095). Forty-seven percent of males had serum IgG4 concentrations 5 times the upper limit of normal (ULN), compared with 29% of the female subjects. Male subjects also had higher mean concentrations of IgE and IgG1 [Table 1]. Mean serum lipase values were lower among the male subjects (P = 0.020). A greater degree of plasmablast expansion was observed in males [Figure 2].

Conclusion: In its predilection for affecting males more often than females, IgG4-RD bears a striking contrast to most other forms of autoimmune disease, which typically have strong female predilections. Male patients with IgG4-RD also appear more likely than females to have multi-organ involvement, to have disease affecting major organs, and to be serologically active as defined by immunoglobulin concentrations in the blood. The lower lipase levels observed in males are consistent with greater degrees of pancreatic damage. Further study is required to understand these sex differences.

Supporting image 1

Table 1. Demographics and Baseline Laboratory Values, By Sex

Supporting image 2

Figure 1. Organ Involvement in female and male patients with IgG4-RD

Supporting image 3

Figure 2. Plasmablast quantitation plot of females and males with active and untreated IgG4-RD


Disclosures: G. McMahon: None; I. Jha: None; A. McMahon: None; A. Fernandes: None; Z. Wallace: BioCryst, 2, Bristol-Myers Squibb(BMS), 5, Horizon, 1, 2, 5, MedPace, 2, Novartis, 1, PPD, 2, Sanofi, 1, 5, Shionogi, 1, Visterra, 1, 2, Zenas, 1, 2; G. Katz: None; C. Perugino: Horizon Therapeutics, 2; J. Stone: Abvie, 2, Amgen, 1, 2, Argenx, 2, Aztrazeneca, 2, Bristol Myers Squibb, 2, 5, Celgene, 2, Chemocentryx, 2, Chugai, 2, GSK, 2, Horizon Therapeutics, 1, 2, 5, InflaRx, 2, IQVIA, 1, 2, Kyverna, 2, Mirabio, 2, NIH, 5, Novartis, 2, PPD, 2, Prometheus, 2, Q32, 2, Regeneron, 2, Roche-Genentech, 2, Roivant, 2, Sanofi, 2, 5, Spruce Biosciences, 2, Star Therapeutics, 2, Steritas, 12, Chair, Scientific Advisory Board (no fiduciary responsibilities), ZenasBio, 2.

To cite this abstract in AMA style:

McMahon G, Jha I, McMahon A, Fernandes A, Wallace Z, Katz G, Perugino C, Stone J. Characterization of Phenotypic Differences in IgG4-Related Disease Across the Sexes [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/characterization-of-phenotypic-differences-in-igg4-related-disease-across-the-sexes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-phenotypic-differences-in-igg4-related-disease-across-the-sexes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology